The effect of syringe exchange use on high-risk injection drug users: A cohort study

AIDS

Volumn 14, Issue 5, 2000, Pages 605-611

  Bluthenthal, Ricky N ^a,b,c   Kral, Alex H ^c   Gee, Lauren ^c   Erringer, Elizabeth A ^c   Edlin, Brian R ^c  

^a RAND CORPORATION   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV prevention; Injection drug use; Intervention; Needle exchange; Risk behaviors

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROBABILITY; REGRESSION ANALYSIS; SYRINGE;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0034119211     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003310-00015     Document Type: Article

References (52)

1. 1. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992-1995. J Acquir Immune Defic Syndr Human Retrovirol 1998, 18:505-511.
2. 2. Paone D, Des Jarlais DC, Shi Q. Syringe exchange use and HIV risk reduction over time [letter]. AIDS 1998, 12:121-123.
3. 3. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Human Retrovirol 1997, 16:400-406.
4. 4. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994, 271:115-120.
5. 5. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996, 348:987-991.
6. 6. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995, 85:1531-1537.
7. 7. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. Am J Epidemiol 1997. 146:994-1002.
8. 8. Bruneau J, Lamothe F, Franco E. RE: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study." [letter]. Am J Epidemiol 1998, 148:716-717.
9. 9. Bruneau J, Franco E, Lamothe F. Assessing harm reduction strategies: the dilemma of observational studies. Am J Epidemiol 1998. 146:1007-1110.
10. 10. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999, 149:203-213.
11. 11. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997, 11:F59-F65.
12. 12. Anon. Interventions to prevent HIV risk behaviors. NIH Consensus Statement, 1997, 15:1-41.
13. 13. General Accounting Office. Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Washington, DC: US General Accounting Office; 1993.
14. 14. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.
15. 15. Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada, J Acquir Immune Defic Syndr Human Retrovirol 1998, 17:160-166.
16. 16. Heimer R. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond. Public Health Rep 1998, 113 [suppl 1]:67-74.
17. 17. Schlechter MT, Strathdee SA, Cornelisse PGA, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS 1999, 13:F45-F51.
18. 18. Fife D, Mode C. AIDS prevalence by income group in Philadelphia. J Acquir Immune Defic Syndr Human Retrovirol 1992, 5:1111-1115.
19. 19. Fife D, Mode C. AIDS incidence and income. J Acquir Immune Defic Syndr Human Retrovirol 1992, 5:1105-1110.
20. 20. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989, 321:874-879.
21. 21. Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Human Retrovirol 1996, 13:273-280.
22. 22. Vlahov D, Munoz A, Anthony J, Cohn S, Celentano D, Nelson K. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990, 132:847-856.
23. 23. Needle RH, Coyle S, Cesari H, et al. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse 1998, 33:2403-2423.
24. 24. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994, 84:382-387.
25. 25. Paone D, Clark J, Shi Q, Purchase D, Des Jarlais DC. Syringe exchange in the United States, 1996: a national profile. Am J Public Health 1999, 89:43-46.
26. 26. Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/ AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles. JAMA 1997, 277:53-62.
27. 27. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Social Problems 1989, 36:416-430.
28. 28. Bluthenthal RN, Watters JK. Multimethod research: from targeted sampling to HIV risk behaviors. In: Qualitative Methods in the Prevention of Drug Abuse and HIV Research. Edited by Lambert EY, Ashery RS, Needle RH. Rockville, MD: National Institute on Drug Abuse; 1995.
29. 29. NIDA. Risk Behavior Assessment. Rockville, MD: National Institute on Drug Abuse; 1991.
30. 30. Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS 1996, 10:1729-1734.
31. 31. Neaigus A, Friedman SR, Goldstein M, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. In: Social Networks, Drug Abuse, and HIV Transmission. Edited by Needle RH, Genser SG, Trotter RT. Rockville, MD: National Institute on Drug Abuse; 1995.
32. 32. Price RK, Cottier LB, Mager D, Murray KS. Injecting drug use, characteristics of significant others, and HIV-risk behaviors. In: Social Networks, Drug Abuse, and HIV Transmission. Edited by Needle RH, Genser SG, Trotter RT. Rockville, MD: National Institute on Drug Abuse; 1995.
33. 33. Neaigus A. The network approach and interventions to prevent HIV among injection drug users. Public Health Rep 1998, 113 [suppl 1]:140-150.
34. 34. Suh T, Mandell W, Latkin C, Kim J. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug Alcohol Depend 1997, 47:137-143.
35. 35. Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: targeting hidden IDU populations with clean needles via know user groups. J Psychoactive Drugs 1992, 24:41-48.
36. 36. Kral AH, Bluthenthal RN. HIV risk behaviors among injection drug users (IDUs) who are indirect syringe exchangers in Oakland and Richmond, California, 1996. Presented at the American Public Health Association 125th Annual Meeting. Indianapolis, IN; November 9-13, 1997.
37. 37. Valente TW, Foreman RK, Junge B, Vlahov D. Satellite exchange in the Baltimore needle exchange program. Public Health Rep 1998, 113(suppl 1):90-96.
38. 38. Crofts N, Louie R, Rosenthal D, Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction 1996, 91:1187-1196.
39. 39. Guydish JR, Abramowitz A, Woods W, Black DM, Sorensen JL. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-1988. Am J Public Health. 1990, 80:995-997.
40. 40. Paone D, Des Jarlais DC, Caloir S, Jose B, Shi Q, Friedman SR. Continued risky injection subsequent to syringe exchange use among injection drug users in New York. Aids Educ Prev 1997, 9:505-510.
41. 41. Fennema JS, van Ameijden EJ, Van den Hoek A, Coulinho RA. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997, 92:1457-1465.
42. 42. Garfein RS, Doherty MS, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr 1998, 18 (suppl 1):S11-S19.
43. 43. Rezza G, Nicolosi A, Zaccarelli M, et al. Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach. J Acquir Immune Defic Syndr 1994, 7:500-503.
44. 44. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Human Retrovirol 1995, 11:499-509.
45. 45. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994, 1:383-392.
46. 46. Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Evaluation and Program Planning. 1994, 17:347-355.
47. 47. Vlahov D, Brookmeyer RS. The evaluation of needle exchange programs [editorial]. Am J of Public Health 1994, 84:1889-1891.
48. 48. Lurie P. Invited commentary: Le mystere de Montreal. Am J Epidemiol 1997, 146:1003-1006.
49. 49. Hagan H, Weiss NS, Thiede H, Hopkins S, McGough JP, Alexander ER. Reply to "Invited commentary: Needle exchange - No help for hepatitis?" by Moss and Hahn. Am J Epidemiol 1999, 149:217-218.
50. 50. Metzger DS, Woody GE, McLellan, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of treatment: an 18-month prospective follow-up. J Aquir Immune Defic Syndr 1993, 6:1049-1056.
51. 51. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998, 12 (suppl A):S217-S230.
52. 52. Lurie P, Reingold AL, Bowser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco: University of California; 1993.